-+ 0.00%
-+ 0.00%
-+ 0.00%

Freedom Capital Markets Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $73

Benzinga·09/09/2026 12:27:00
語音播報
Freedom Capital Markets analyst Keith Hinton initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $73.